Smart Insulin Pens Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150

13:44 EST 3 Feb 2018 | BioPortfolio Reports

According to Stratistics MRC, the Global Smart Insulin Pens Market is accounted for $58 million in 2016 and expected to grow at a CAGR of 12.2% to reach $130 million by 2023. Factors influencing the market growth are concerns for continuous glucose monitoring, introducing devices with smart connectivity and increasing diabetic patient pool. In addition, demand for personalized or patient centric devices and preventing the needle stick injury provide opportunity for the market. However, blood sugar control is the most challenging aspect as well as security concern and high costs of smart pens are restraining the market growth.

Based on type, Bluetooth connected smart insulin pens logs injected insulin doses directly to the patient's digital blood glucose through the Bluetooth wireless interface. The software records each dose accurately and transfers readings into MRAM, and waits for activation of the Bluetooth Smart radio. If, the insulin delivery data doesn't transfer to the phone then, it's stored in the pen, gets ready for the next attempt as soon as the capacitor is recharged. Bluetooth Smart SoC is a unique and effective concept for insulin delivery pens. The pen has combination with other electronic tools, which can lead to glucose control accessible and affordable, which in turn assists in reducing complications and helps patients lead longer lives. BULE or Bluetooth Smart technology provides secure 128 bit encrypted data transfer capabilities.

North America dominated the smart insulin pens market owing to high persistence of obsolete syringe technology and rising prevalence of diabetes. However, Asia Pacific is the fastest growing market due to increase in prevalence with age and provides new treatment opportunities.

Some of the key players in the Global Smart Insulin Pens market are Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, Roche, Insulet, Cardiocomm Solutions, BioSampling, Megasan Medical, Emperra GmbH EHealth Technologies, Nipro, Jiangsu Delfu medical device Co.,Ltd and Sanofi Diabetes.

Usabilities Covered:

Reusable Pens

PreFilled Pens

Indications Covered:

Diabetes Type I

Diabetes Type II

Types Covered:

Second Generation Pens

o USB connected pens

o Bluetoothenabled pens

First Generation Pens

Distribution Channels Covered:

Ambulatory Surgical Centers

Home Care Settings

Hospitals Clinics

Retail Pharmacies


Fabrications Covered:



Technologies Covered:


Jet Injectors

Spring loaded

Regions Covered:

North America

o US

o Canada

o Mexico


o Germany

o UK

o Italy

o France

o Spain

o Rest of Europe

Asia Pacific

o Japan

o China

o India

o Australia

o New Zealand

o South Korea

o Rest of Asia Pacific

South America

o Argentina

o Brazil

o Chile

o Rest of South America

Middle East Africa

o Saudi Arabia


o Qatar

o South Africa

o Rest of Middle East Africa

What our report offers:

Market share assessments for the regional and country level segments

Market share analysis of the top industry players

Strategic recommendations for the new entrants

Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets

Market Trends Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations

Strategic recommendations in key business segments based on the market estimations

Competitive landscaping mapping the key common trends

Company profiling with detailed strategies, financials, and recent developments

Supply chain trends mapping the latest technological advancements

Original Article: Smart Insulin Pens Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150


More From BioPortfolio on "Smart Insulin Pens Global Market Outlook 20172023 [Report Updated: 01112017] Prices from USD $4150"

Quick Search

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...